Skip to main content
logo
Alebund Pharmaceuticals (Jiangsu) Limited (HKG:9637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
28.58
+1.92 (7.20%)
At close: Oct 7, 2026

HKG:9637 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Income
-703.81-750.04-326.03
Depreciation & Amortization
45.7344.6112.52
Other Amortization
0.130.130.03
Loss (Gain) From Sale of Assets
0.10.10
Loss (Gain) From Sale of Investments
-1.1-1.95-
Loss (Gain) on Equity Investments
37.392.82-0
Stock-Based Compensation
274.23260.7621.9
Other Operating Activities
-27.53108.6616.02
Change in Accounts Receivable
-0.360.87-0.87
Change in Inventory
-6.9-4.15-6.12
Change in Accounts Payable
64.2774.064.13
Change in Unearned Revenue
11.789.0230.77
Change in Other Net Operating Assets
-27.88-32.78-2.26
Operating Cash Flow
-333.94-287.89-249.9
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Capital Expenditures
-71.53-101.62-230.63
Sale (Purchase) of Intangibles
---6.04
Investment in Securities
117.82-148.38-13.55
Other Investing Activities
5.9913.18-7.2
Investing Cash Flow
52.27-236.82-257.41

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Short-Term Debt Issued
--32.55
Long-Term Debt Issued
-145.03384.62
Total Debt Issued
76.39145.03417.18
Short-Term Debt Repaid
---528.83
Long-Term Debt Repaid
--118.05-57.21
Lease Payments
-4.97-5.05-5.69
Total Debt Repaid
-4.97-118.05-586.03
Net Debt Issued (Repaid)
71.4226.97-168.86
Issuance of Common Stock
1,418535.781,345
Other Financing Activities
-27.19-21.04-388.19
Financing Cash Flow
1,462541.72787.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Foreign Exchange Rate Adjustments
-6.94-2.450.26
Net Cash Flow
1,17414.56280.62

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-405.48-389.51-480.52
Free Cash Flow Growth
---
Free Cash Flow Margin
-330.72%-1274.74%-7364.34%
Free Cash Flow Per Share
-1.49-1.59-1.77
Levered Free Cash Flow
--1,950-
Unlevered Free Cash Flow
--1,881-
Free Cash Flow After Leases
-410.44-394.56-486.22

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash Interest Paid
18.8718.9914.57
Change in Working Capital
40.9247.0225.66